PCRX vs EVO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jun 17, 2026
PCRX
EVO
Investment Advisor Scores
EVO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | EVO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.8555 | 53.4759 | PCRX |
| PEG Ratio | 11.2121 | 1.4223 | EVO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.0% | -21.7% | PCRX |
| Earnings Growth | -30.0% | 0.0% | EVO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 57.1/100 | 52.2/100 | PCRX |
| Profit Margin | 0.7% | -26.0% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |